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Background: One hallmark of uremia is the impairment of neuro-cognitive function. Anecdotal clinical description
from the early days of chronic dialysis therapy impressively illustrates the improvement of those functions by
chronic hemodialysis treatment. Fortunately, today, uremia is only rarely observed in industrialized countries as
many patients seek medical/nephrological attention prior to the occurrence of deadly complications of uremia.
Case presentation: We report a rare case of severe uremia and describe the day to day improvement in neuro-
cognitive function by dialysis using state of the arte test battery – starting at a serum creatinine of 2443 μmol/l.
Conclusions: Especially executive functions, which are assumed to be localized in the frontal cerebral regions, are
impaired in severe uremia and improve remarkably with the correction of severe uremia, i.e. initiation of dialysis.
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In 1847 Piorry coined the term “uremia” describing a
multi-facetted clinical syndrome consisting of digestive
and neurological abnormalities secondary to renal failure
and the resulting endogenous intoxication [1]. One well
documented finding in patients with chronic kidney dis-
ease (CKD) is the impairment of cognitive function.
Kurella et al. could show that decreased eGFR (estimated
glomerular filtration rate) in postmenopausal woman is
associated significantly with impairment in global cogni-
tion, executive function, language, and memory [2]. In a
community-based cross-sectional study Elias et al. found
that global performance and specific cognitive functions
are negatively affected early in CKD [3]. Interestingly not
only a decrease in GFR but also elevated urinary albumin/
creatinine ratios is independently associated with faster
decline in cognitive function [4]. Moreover, moderate
renal impairment, has been shown to be associated with
an excess risk of incident dementia among individuals in
good to excellent health [5]. The pathophysiological
mechanism for this is still not clearly understood and
range from urea to the endogenous NOS inhibitor ADMA
[6,7]. Moreover, there are no simple screening tools to
diagnose cognitive function in CKD5D patients [8] While
there is no doubt that severe uremia impairs cognitive* Correspondence: Kielstein@yahoo.com
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reproduction in any medium, provided the orfunction, the effect of a single dialysis session or dialysis
intensity on cognitive impairment is controversially dis-
cussed. One study could not find any effect of a single dia-
lysis on insensitive test like minimental state examination
[9]. Other authors reported that the removal of uremic
toxins by hemodialysis lead to an improvement in cogni-
tive processing [10]. Also the potential effect of an in-
crease of dialysis intensity on cognitive discussion is
controversially discussed. While one pilot study in 12
patients showed improved general cognitive efficiency
6 months after switching from thrice weekly to nocturnal
hemodialysis [11] results from the frequent hemodialysis
network nocturnal trial showed no effect of increased dia-
lysis intensity on cognitive performance, measured by
Trail Making Test B only [12]. We monitored the neuro-
cognitive function of a patient with severe uremia in
chronic humoral rejection secondary to non-adherence to
immunosuppressive therapy after renal transplantation,
starting at a serum creatinine of 2443 μmol/l.Case presentation
A 27-year-old pale Caucasian male was admitted into
the emergency room of our tertiary care hospital with
the diagnosis of uremia. Upon arrival the overweight pa-
tient (BMI 32.7 kg/m²) had a blood pressure of 164/
91 mmHg and a heart rate of 110/min. He presented
with nausea and diarrhea, but was alert and awake. The
remainder of the physical examination showed pericar-
dial friction rub as well as a uremic foetor. His mucusral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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was significant for a living related kidney transplantation
in 2008 for chronic interstitial nephritis and reflux
nephropathy.
About ten weeks prior to the admission he stopped
taking the immunosuppressive medication which con-
sisted of tacrolimus, prednisolone and mycophenolat-
mofetil. The main reason for discontinuation was al-
legedly his financial situation after a job loss, which did
not allow him to pay the necessary co-payment for the
immunosuppressive drugs. He did neither seek help
from the hospital nor from the welfare authorities/social
services. Laboratory analysis was remarkable for a serum
creatinine of 2443 μmol/l a serum urea of 67.6 mmol/l
and a serum phosphorous level of 2.69 mmol/l. His ven-
ous blood gas analysis showed a metabolic acidosis
(pH 7.27, bicarbonate 14 mmol/l). He was anemic with a
hemoglobin level of 6.9 g/dl.) Renal biopsy showed a
severe irreversible damage of the graft due to chronic
humural rejection. After transfer to our unit hemo-
dialysis was initiated. The patient also received two units
of packed red blood cells, which lead to an increase in
hemoglobin level to 8.8 g/dl. Peak creatinine declined
under the initiation of dialysis. Due to an ongoingFigure 1 Reduction of creatinine by dialysis and concomitant improv
trail making test A 25 circles are distributed over a sheet of paper, number
numbers in ascending order as fast as possible.research project on the evaluation of cognitive function
in dialysis patients we were able to use a battery of
established test for neuro-cognitive function for frequent
monitoring. The patient consented to take part in fre-
quent psychological tests consisting of computer-based
attention tasks, memory tasks (short-term and long-
term memory) and also several tasks to examine execu-
tive functions. The full test battery consisted of Wechs-
ler Digit Span, Stories of Rivermead Behavioral Memory
Test (RBMT), TMT A and B, Alertness and Go/NoGo
subtest of Testbatterie zur Aufmerksamkeitsprüfung
(TAP), Key Search and Zoo Map of Behavioral
Assessment of the Dysexecutive Syndrome (BADS),
Regensburger Wortflüssigkeitstest (RWT) as well as Rey
Complex Figures.
The neuropsychological assessments were conducted
by trained personal in a quiet environment. Tests were
all performed between 08:00 and 10:00 AM to minimize
the effect of circadian changes. To retain and optimize
the patients´ compliance and motivation as well as to
avert effects of interference between the several
domains, the tests alternate in the order related to their
verbal and visuo-constructive characteristic. Initial prac-
tice trails were administered for the following testsement of the trail making test A in a uremic patient. (Figure 1a) In
ed 1 to 25 (Figure 1b). The patient should draw lines to connect the
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was understood by the patient. Tests with known train-
ing effects were not regularly repeated. The test battery
with no or minimal influence by learning effects con-
sisted of Wechsler Digit Span, Stories of RBMT, TMT A
and B, Alertness and Go/NoGo subtest of TAP as well
as Rey Complex Figures [13].
In parallel to the correction of uremia, indicated by the
marker substances creatinine, urea we saw general im-
provement of cognitive function (Figure 1a, 2, 3). How-
ever, after the first hemodialysis the patient showed the
lowest performance, possibly due to a slight disequilib-
rium syndrome despite the fact that the first hemodialysis
lasted only 120 minutes. The disequilibrium syndrome is
caused by rapid removal urea resulting in an increased
osmolality in the brain tissue (as compared to the serum)Rey Complex Figure to copy on admission: 
Figure 2 Rey Complex Figure to copy on admission. Recall (after
three minutes) at baseline during uremia.leading to water flux in the brain. i.e. cerebral edema. In-
deed, in our patient there was a small but steady decrease
in the calculated serum osmolality (Table 1). The neuro-
psychological performance is reported in the Table 1.
Scores on Wechsler Digit Span (forward) increased with
ongoing testing. Further verbal memory performance,
tested with Stories of RBMT, also increased. But in RBMT
we found a performance loss on the second testing. All in
all the short-term memory performance (on Wechsler
Digit Span and RBMT) improved on the last testing com-
pared with the first testing. Figural memory performance
in Rey Complex Figures was consistently in an average
range, (Table 1 and Figure 3), except for the second test-
ing, were we found a marked decrease in performance
(Figure 2). Patient´s memory span plus standardized
scores of verbal and figural memory showed no evidence
of neuropsychological deficits for the patient compared to
established control ranges. Interestingly, in the computer-
based alertness attention task, we also found an improve-
ment concomitant with the improvement of uremia. The
assessment of executive functions after admission showed
a marked underperformance even after correcting for the
patients´ age. Concomitant with the initiation of dialysis
therapy the patient considerably improved. PerformanceRey Complex Figure to copy before discharge: 
Figure 3 Rey Complex Figure to copy before discharge. Recall
(after three minutes) after the fourth dialysis sessions.
Table 1 Raw scores and percentile of neuropsychological test battery
RAW SCORES (PERCENTILE)
test # 1 test # 2 test # 3 test # 4 test # 5 test # 6
Hospital day # TESTS 1 2 4 5 7 8
Story RBMT (words)
recall 8 5.5 10 11 11.5 13
Rey Complex Figure
Immediate and delay 41(58–62) 13 (10) 42.5 (62–66) 40 (58) 50 (79) 35 (46–50)
Wechsler Digit Span
forward 6 6 7 7 7 9
backward 5 4 6 6 6 6
Trail Making Test (seconds)
A 55 (<10) 45 (<10) 34 (10–20) 35 (10–20) 31 (20–30) 24 (40–50)
B 129 (<10) 109 (<10) 101 (<10) 74 (<10) 73 (<10) 64 (20)
B/A 2.3 2.4 3.0 2.1 2.4 2.7
TAP (milliseconds)
Alertness
with acoustic signal 260± 57 (24) 226± 47 (38) 216± 30 (38) 273± 40 (12–14) 208± 27 (50) 200± 31 (73)
without acustic signal 279± 49 (10) 241± 34 (31) 233± 29 (38) 257± 39 (27) 225± 38(58) 207± 23 (73)
RWT (words)
lexical 15 (50–75) 17 (50) 20 (84)
lexical-change 15 (10–25) 15 (16–25) 15 (10–25)
semantic 22 (<10) 23 (16) 26 (25–50)
semantic-change 26 (>90) 16 (23) 28 (>90)
Laboratory parameters Serum Creatinin (μmol/l) 2443 1599 1097 948 629
Serum Urea (mmol/l) 67.6 41.6 32.7 29.9 17.8
Phosphorus (μmol/l) 2.69 2.21 2.07 ./. ./.
Sodium (mmol/l) 138 139 139 136 139
Calculated osmolality (mosmol/l) 348 336 325 316 311
Hemoglobin (g/dl) 6.3 8.8 7.6 7.8 8.7
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During the whole test period we observed an improve-
ment from underperformance to average performance.
Accordingly to TMT B we found a salient increase not
until the fourth testing. TMT A and B performance was
perfectly correlated with the correction of the serum cre-
atinine level (Spearman's rank correlation: rs=1.0, p <.05).
Nevertheless the performance on TMT B was clearly
below-average, thereby indicating a continuous deficit in
cognitive function, which is only “average” in the last of
the all tests. The correction of uremia only slightly
improved verbal fluency tasks (RWT).
Conlcusions
The first report on the treatment of chronic uremia by
intermittent hemodialysis by Scriber in 1960 identified
already the main problems in treating CKD 5 D patients
[12]. Aside from anemia, sodium and fluid overload aswell as hypertension Scribner et al. describe “increased
fatigability, muscle cramps, irritability and lethargy” as
symptoms of uremia. Sufficient intensity of dialysis in
the first two chronic hemodialysis patients lead to a situ-
ation in which “neither patient has yet shown the relent-
less loss of weight and the mental deterioration which
has been encountered in the past when less intensive dia-
lysis therapy was employed”. This description epitomizes
that at least some of the alterations in cognitive function
in uremia are reversible in nature and could be due to
the accumulation of uremic toxins. To our knowledge
we report for the first time a sequential examination of a
patient in severe uremia using an extensive state of the
art battery of neurocognitive tests. A widespread armen-
tarium has previously only been employed in a cross-
sectional study of chronic hemodialysis patients [13]. A
study comparing the effect of acute removal of uremic
toxins has to our knowledge so far not been conducted.
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(CNV) recorded with electroencephalogram 1 h before
and 1 h after a dialysis session finding no significant dif-
ference [14]. The neuropsychological tests (MMSE and
TMT) they used were only for a cross-sectional analysis
and not to compare pre- and post- dialysis cognitive sta-
tus. Williams et al. studied patients at intervals of 1, 24,
and 67 hours after the last weekly hemodialysis session
and found fluctuations in memory and attention with a
time dependent increase in impairment after the dialysis
session [15].
The very nature of a case report does not allow gener-
alizing the results we obtained in a peculiar case of
uremia. Nonetheless we conclude that especially execu-
tive functions, which are assumed to be localized in the
frontal cerebral regions, are impaired in severe uremia
and improve remarkably with the initiation of dialysis
treatment.
Consent
Written consent was obtained from the patient for pub-
lication of this study. Ethical approval was for reporting
this case was obtained from the Medical School
Hannover.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SS and AM conducted the neurocognitive testing. OB and JTK were the
treating physicians of the patient reported. SS, JTK and RS evaluated the test
results. All of the authors have participated in the discussion and in writing
of the submitted manuscript. All authors read and approved the final
manuscript.
Acknowledgement
The publication of the study is supported by the DFG-project “Open Access
Publication” at the Medical School Hannover.
Author details
1Department of Psychology, Martin-Luther University, Halle-Wittenberg,
Germany. 2Department of Nephrology and Hypertension, Medical School
Hannover, Hanover, Germany.
Received: 3 April 2012 Accepted: 18 June 2012
Published: 15 August 2012
References
1. Richet G: Early history of uremia. Kidney Int 1988, 33:1013–1015.
2. Kurella M, Yaffe K, Shlipak MG, Wenger NK, Chertow GM: Chronic kidney
disease and cognitive impairment in menopausal women. Am J Kidney
Dis 2005, 45:66–76.
3. Elias MF, Elias PK, Seliger SL, Narsipur SS, Dore GA, Robbins MA: Chronic
kidney disease, creatinine and cognitive functioning. Nephrol Dial
Transplant 2009, 24:2446–2452.
4. Sajjad I, Grodstein F, Kang JH, Curhan GC, Lin J: Kidney dysfunction and
cognitive decline in women. Clin J Am Soc Nephrol 2012, 7:437–443.
5. Seliger SL, Siscovick DS, Stehman-Breen CO, Gillen DL, Fitzpatrick A, Bleyer
A, Kuller LH: Moderate renal impairment and risk of dementia among
older adults: the Cardiovascular Health Cognition Study. J Am Soc
Nephrol 2004, 15:1904–1911.
6. Kielstein JT, Kielstein A: ADMA and the brain: an unfolding story. Am J
Hypertens 2009, 22:240.7. Kielstein JT, Suntharalingam M, Perthel R, Rong S, Martens-Lobenhoffer J,
Jager K, Bode-Boger SM, Nave H: Asymmetric dimethylarginine may
mediate increased heat pain threshold in experimental chronic kidney
disease. Nephrol Dial Transplant 2012, 27:899–902.
8. Sorensen EP, Sarnak MJ, Tighiouart H, Scott T, Giang LM, Kirkpatrick B, Lou K,
Weiner DE: The kidney disease quality of life cognitive function subscale
and cognitive performance in maintenance hemodialysis patients. Am J
Kidney Dis 2012. doi:10.1053/j.ajkd.2011.12.029.
9. Dahbour SS, Wahbeh AM, Hamdan MZ: Mini mental status examination
(MMSE) in stable chronic renal failure patients on hemodialysis: The
effects of hemodialysis on the MMSE score. A prospective study.
Hemodial Int 2009, 13:80–85.
10. Madan P, Agarwal S, Kalra OP, Tandon OP: Effect of hemodialysis on
cognitive function in ESRD patients. Ren Fail 2007, 29:699–703.
11. Jassal SV, Devins GM, Chan CT, Bozanovic R, Rourke S: Improvements in
cognition in patients converting from thrice weekly hemodialysis to
nocturnal hemodialysis: a longitudinal pilot study. Kidney Int 2006,
70:956–962.
12. Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T,
Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW,
Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA,
Kliger AS, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine
B, Mohr P, Beck G, Fu Z, Gassman J, Greene T, Daugirdas J, Hunsicker L,
Larive B, Li M, Mackrell J, Wiggins K, Sherer S, Weiss B, Rajagopalan S, Sanz J,
Dellagrottaglie S, Kariisa M, Tran T, West J, Unruh M, Keene R, Schlarb J,
Chan C, McGrath-Chong M, Frome R, Higgins H, Ke S, Mandaci O, Owens C,
Snell C, Eknoyan G, Appel L, Cheung A, Derse A, Kramer C, Geller N, Grimm
R, Henderson L, Prichard S, Roecker E, Rocco M, Miller B, Riley J, Schuessler
R, Lockridge R, Pipkin M, Peterson C, Hoy C, Fensterer A, Steigerwald D,
Stokes J, Somers D, Hilkin A, Lilli K, Wallace W, Franzwa B, Waterman E, Chan
C, McGrath-Chong M, Copland M, Levin A, Sioson L, Cabezon E, Kwan S,
Roger D, Lindsay R, Suri R, Champagne J, Bullas R, Garg A, Mazzorato A,
Spanner E, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Pierratos A,
Chan W, Regozo K, Kwok S: The effects of frequent nocturnal home
hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney
Int 2011, 80:1080–1091.
13. Wagner S, Helmreich I, Dahmen N, Lieb K, Tadic A: Reliability of three
alternate forms of the trail making tests a and B. Arch Clin Neuropsychol
2011, 26:314–321.
14. Bae JS, Park SS: Contingent negative variation before and after
hemodialysis among patients with end-stage renal disease. J Neurol Sci
2008, 267:70–75.
15. Williams MA, Sklar AH, Burright RG, Donovick PJ: Temporal effects of
dialysis on cognitive functioning in patients with ESRD. Am J Kidney Dis
2004, 43:705–711.
doi:10.1186/1471-2369-13-86
Cite this article as: Schneider et al.: Cognitive function at 2443 μmol/l
creatinine. BMC Nephrology 2012 13:86.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
